Cost-effectiveness of neonatal screening for Duchenne muscular dystrophy—How does this compare to existing neonatal screening for metabolic disorders?-Reference-Cited by-同舟云学术

Cost-effectiveness of neonatal screening for Duchenne muscular dystrophy—How does this compare to existing neonatal screening for metabolic disorders?

Published:1993-08 Issue:4 Volume:37 Page:541-547
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Rosenberg T.,Jacobs H.K.,Thompson R.,Horne J.M.

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health(social science)

Reference25 articles.

1. Newborn screening for Duchenne muscular dystrophy;Zellweger;Pediatrics,1975

2. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary organization of the DMD gene in normal and affected individuals;Koenig;Cell,1987

3. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy;Bakker;Lancet,1985

4. Screening for Duchenne muscular dystrophy;Dubowitz;Arch. Dis. Child.,1976

5. Editorial. Screening of the newborn for Duchenne muscular dystrophy;Br. Med. J.,1975

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies;Genetics in Medicine;2021-03

2. The potential and benefits of repurposing existing drugs to treat rare muscular dystrophies;Expert Opinion on Orphan Drugs;2018-03-20

3. Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation;Health Technology Assessment;2017-05

4. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence;Health Policy;2015-07

5. Duchenne muscular dystrophy: issues in expanding newborn screening;Current Opinion in Pediatrics;2007-12